NCT04775732View on ClinicalTrials.gov

Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

August 31, 2019

Study Completion Date

September 30, 2019

Conditions
Crohn DiseaseUlcerative Colitis
Interventions
BIOLOGICAL

infliximab therapeutic drug monitoring

dose optimization of infliximab based on a predefined dosing algorithm

Trial Locations (2)

2820

Imelda GI clinical research center, Bonheiden

9000

AZ Sint Lucas, Ghent

Sponsors
All Listed Sponsors
lead

Imelda GI Clinical Research Center

OTHER